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Abstract
Properties of ligand-gated ion channels such as a4^2 nicotinic acetylcholine receptors 
(nAChRs) and their interactions with various pharmacologic compounds have been studied using 
voltage clamping techniques for decades. The peak current amplitude, measured in whole-cell 
experiments, gives us an idea of how receptors will respond to a ligand in situ. Some ligands 
have the potential to potentiate the peak amplitude, by various mechanisms such as 
destabilization of receptor desensitized states. The ability of a ligand to increase the peak 
amplitude of a4^2 nAChRs has the potential to treat a variety of neuronal disorders; however 
unique properties of these receptors such as fast activation and long-lived desensitized states 
create significant challenges in determining the extent of modulation of the peak current using 
these techniques. To correctly assess the peak amplitude, the experiment must achieve 
synchronous activation of all surface receptors by optimizing solution exchange rates. Failure to 
do so leads to blunted peak-amplitude measurements in acetylcholine (ACh).
This study found that previous reports of the modulating effects of 
desformylflustrabromine (dFBr), a positive allosteric modulator (PAM) of a4^2 nAChRs, 
neglected to account for the large surface area of Xenopus oocytes and slow solution exchange 
rates, leading to an artificially large potentiation of the peak current in dFBr. This study utilized 
cell lines with a relatively small surface area and a high-speed perfusion system to achieve fast 
solution exchange rates, and found the potentiation of the peak current by dFBr to be ~1.5-fold. 
Further studies involving PAMs of a4^2 nAChRs should take necessary steps to optimize 
solution exchange rates to improve accuracy and reproducibility of their results.
In addition, analysis of the whole-cell responses of a4^2 nAChRs to dFBr and ACh 
have lead to new insights on their effect on not only the peak amplitude, but also on the time-to
v
peak, and the steady-state current. On average, we found that dFBr decreased the time-to peak by 
38% and increased the steady-state current ~1.5-fold. Further studies should also consider 
modulation of the steady-state current to be just as, if not more important than the peak 
amplitude, as this feature may be a better predictor of the therapeutic benefit of PAMs of a4^2 
nAChRs.
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Chapter 1: Introduction
1.1 Summary and Overall Project Aim
Nicotinic acetylcholine receptors belong to a family of ligand-gated ion channels that 
mediate synaptic transmission in the central nervous system. nAChRs are proteins composed of 
five subunits that span the plasma membrane and assemble in the form of a rosette with a central, 
water-filled pore (Gotti et al., 2009). In response to release of acetylcholine (ACh) from a 
presynaptic neuron, nAChRs, located on a (downstream) postsynaptic neuron, bind ACh and 
undergo conformational changes that result in the opening of the central pore. Influx of 
monovalent and divalent cations through the pore generates an electrical signal that modulates 
the firing pattern of the postsynaptic neuron (Gay & Yakel, 2007; Williams, Wang, & Papke, 
2011).
The functional roles of nAChRs in the CNS are not well defined; however, errors in 
signaling at cholinergic synapses due to inappropriate expression of nAChRs are associated with 
cognitive deficits (Perry et al., 2001), nicotine addiction (Xiao et al., 2009), and a variety of 
catastrophic diseases including Alzheimer’s and Parkinson’s disease (Court et al., 2001; Perry et 
al., 1987). A novel class of drugs called positive allosteric modulators (PAMs) targets nAChRs 
and changes their responses to the binding of acetylcholine. Compounds that enhance or 
potentiate responses of nAChRs could potentially boost transmission at synapses where nAChRs 
are underexpressed (deficient) and thereby restore the functional properties of underlying circuits 
(Williams et al., 2011).
Desformylflustrabromine (dFBr) is a PAM of a subtype of nAChRs that are composed of 
a4 and ^2 subunits (Weltzin & Schulte, 2010; Kim et al., 2007). The effects of dFBr on
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activation of a4p2 nAChRs has so far been limited to studies of receptors expressed in oocytes. 
Solution exchange times are slow for the oocyte preparation (Weltzin & Schulte, 2010) relative 
to the activation time of a4p2 nAChRs (~10 ms) (Grupe, Jensen, Ahring, Christensen, & 
Grunnet, 2013; Paradiso & Steinbach, 2003), which limits the information that can be obtained 
concerning the mechanism of action of dFBr on a4p2 nAChRs. The overall aim of this study 
was to investigate the properties of dFBr on a4p2 nAChRs expressed in SH-EP1 cells using fast, 
step increases in ACh concentration (concentration jumps). Using a novel apparatus that allowed 
for fast changes in ACh concentration, we were able to characterize the effect of dFBr on 
nAChR responses characteristic of receptors in vivo.
1.2 Types of Receptor Subunits
The types of subunits, and the order in which they are arranged, determines how nAChRs 
interact with ACh and other chemical compounds such as agonists and allosteric modulators. 
Neuronal nAChRs are composed of a  (a2-a10) and p (^2-^4) subunits, which form homomeric 
and heteromeric receptors (Gotti, Zoli, & Clementi, 2006). The major class of nAChRs in the 
brain is composed a4 and p2 subunits that can assemble in alternate receptor stoichiometries 
(Nelson, Kuryatov, Choi, Zhou, & Lindstrom, 2003). Low sensitivity a4p2 nAChRs (LS) are 
composed of three a4 subunits and two p2 subunits, whereas high sensitivity a4p2 nAChRs 
(HS) are composed of three p2 subunits and two a4 subunits (Carbone, Moroni, Groot- 
Kormelink, & Bermudez, 2009; Moroni, Zwart, Sher, Cassels, & Bermudez, 2006; Mazzaferro et 
al., 2014; Kuryatov, Onsken, & Lindstrom, 2008). These differences in stoichiometry have a 
significant effect on single-channel conductance (Nelson et al., 2003; Li & Steinbach, 2010) and 
sensitivity to agonists, partial agonists, and antagonists (Carbone et al., 2009; Moroni et al.,
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2006; Mazzaferro et al., 2014; Kuryatov et al., 2008). Activation of HS receptors requires the 
binding of two ACh molecules, one at each of the a4/p2 interfaces. Recent studies suggest that 
activation of a third ACh binding site on the a4/a4 interface is also required for full activation of 
LS receptors (Harps0e et al., 2011; Mazzaferro et al., 2011).
1.3 Functional Properties of Ligand-Gated Ion Channels
Essential to the signaling role of ligand-gated ion channels is their ability to transition 
from closed to open conformational states in response to ligand binding. At typical resting 
membrane potentials, binding of ACh (released from presynaptic neurons) results in sodium ion 
influx through open nAChRs, depolarizing the postsynaptic membrane. Following termination of 
the release process, the concentration of ACh at receptors decreases, primarily due to the activity 
of acetylcholinesterase (AChE), and the probability of nAChRs returning to a closed state 
(available for activation) increases (Williams et al., 2011). If exposure to an agonist is prolonged, 
as is expected if AChE inhibitors are present, or exogenous agonists (nicotine, e.g.) are used, 
nAChRs enter long-lived closed, or “desensitized” states, in which ligand binding no longer 
results in channel opening (Paradiso & Steinbach, 2003).
1.4 The Effects of nAChR Activation on Circuits
nAChRs are found throughout the central nervous system and act primarily by 
modulating the activity of other neurotransmitter-releasing neurons (Dani & Bertrand, 2009;
Gotti et al., 2009). Dysfunction of nAChRs is implicated in several neuronal disorders. The type 
of dysfunction is dependent on the disease. In patients with Alzheimer’s disease (AD), for 
example, studies indicate a net decrease in expression of certain nAChR subunits as well as a
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decrease in high-affinity nicotine binding sites within the cortex, striatum, and thalamus (Court 
et al., 2001). Other studies have shown that the cognitive symptoms associated with 
schizophrenia (Miwa, Freedman, & Lester, 2011) and autism (Lee et al., 2002; Perry et al., 2001) 
can be associated with a decrease in nAChR expression, while nicotine addiction (Govind,
Walsh, & Green, 2012; Xiao et al., 2009) is believed to occur as a result of desensitization that 
apparently triggers upregulation of a4p2 nAChRs. These and other disorders may be treatable, at 
least in part, by compounds that increase the activity of nAChRs in an attempt to offset the errors 
in cholinergic signaling that occur as a result of underexpression or desensitization.
1.5 The Problem of Receptor Desensitization for Drug Design
The rapid desensitization of nAChRs as a result of prolonged exposure to an agonist is a 
potential obstacle for developing effective treatment options for diseases related to dysfunctional 
cholinergic signaling. For example, the efficacy of AChE inhibitors used in the treatment of 
Alzheimer’s disease (AD) has been questioned (Birks, 2006), perhaps because these drugs do 
little to prevent desensitization of nAChRs despite their role in maintaining a relatively high 
concentration of ACh at cholinergic synapses (Quick & Lester, 2002). Moreover, they lack 
specificity, leading to poor side-effect profiles (Birks, 2006). It is, therefore, imperative that 
science and medicine look towards developing pharmacologic agents that not only act on 
specific nAChR subtypes, but also overcome the obstacle of rapid and profound desensitization. 
These new compounds may be used in place of, or as an adjunct to current treatment modalities.
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1.6 Positive Allosteric Modulators of a4p2 nAChRs
PAMs are compounds that bind to allosteric sites on the receptor, leaving the canonical 
orthosteric sites free and available to bind agonists (Changeux & Edelstein, 2005). PAMs can act 
by increasing response amplitude, either by increasing the maximum response to a saturating 
concentration of agonist (all receptors occupied), by decreasing the concentration of ACh 
required to achieve a half-maximal response, or by increasing the conductance of the ion 
channels (Pandya & Yakel, 2011b; Changeux & Edelstein, 2005; Williams et al., 2011).
Some commonly used drugs act by an allosteric mechanism. Benzodiazepines and 
barbiturates, for example, are PAMs of GABAa receptors. On a molecular level, benzodiazepines 
increase the frequency of receptor opening, while barbiturates act by increasing the mean 
receptor open time (Trevor & Way, 2009). Allosteric modulation, however, is not unique to 
pharmacology. In fact, many endogenous steroid hormones and peptides act as allosteric 
modulators, and play an integral role in the regulation of receptor activity in vivo (Williams et 
al., 2011; Pandya & Yakel, 2011b). Research involving allosteric modulators of a4p2 nAChRs 
has shown considerable promise for the treatment of AD (Pandya & Yakel, 2011a) schizophrenia 
(Timmerman et al., 2012), and nicotine addiction (Liu, 2013).
Desformylflustrabromine is a PAM of a4p2 nAChRs. It is a tryptamine-derived 
metabolite from the marine bryozoan Flustra foliacea (Kim et al., 2007; Peters, Kong, Terlau, & 
Wright, 2002). When tested on a variety of nAChR subtypes, dFBr was found to potentiate the 
peak (macroscopic current) responses to ACh up to 3-fold in Xenopus laevis oocytes 
heterologously expressing a mixture of both HS and LS receptors (Sala et al., 2005; Weltzin & 
Schulte, 2010). Weltzin and Schulte (2010) also demonstrated that dFBr rescues the same
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population of nAChRs from desensitization, and proposed that disruption of desensitized states, 
or stabilization of open states relative to desensitized states is the mechanism by which dFBr 
potentiates the macroscopic current.
1.7 Electrophysiology Methods: Voltage Clamping
Voltage-clamping is a method that allows one to measure the response of nAChRs and 
other ligand-gated ion channels via measurements of the current flowing through open, activated 
channels. In a whole-cell voltage-clamp experiment a single electrode is used to control ion 
concentrations within the cell, maintain a constant membrane potential, and measure changes in 
electrical activity of a cell membrane (Hammond, 2008).
Using this technique, one can record the electrical activity across the membrane of a cell, 
or, in the case of a modified “patch-clamp” method, of a single ion channel. Analysis of single­
channel and whole-cell recordings provides insights regarding the mechanism by which a 
compound alters receptor kinetics. Single-channel data allows one to determine the unitary 
conductance of the open channel, as well as distributions of channel open times and shut times 
for a receptor at a particular drug concentration. This information can then be used to construct a 
plausible model for channel gating and calculate the rate constants that govern the transitions 
between various, connected states of the receptor (Hammond, 2008). These kinetic models can 
then be used to simulate whole-cell responses to a range of concentration profiles of agonist to 
compliment, and add to findings obtained from whole-cell data.
Whole-cell voltage-clamp recordings yield waveforms that represent changes in current 
passing through the cell membrane, corresponding to shifts in the conformational states of the 
receptors expressed on the surface of a cell. In the case of nAChRs, the expected response to a
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maintained increase in agonist concentration is a transient influx of cations as nAChRs move 
from a closed, resting state (conformation), to mostly open states, which then enter long-lived, 
non-conducting desensitized states. Eventually, the whole-cell current reaches a steady-state, in 
which the open, closed, and desensitized states of all receptors are in equilibrium. The magnitude 
of the steady-state current will change as the rate constants, which determine the probability of 
entering and leaving the various conformational states, change due to exposure to compounds 
such as dFBr which modulate the gating properties of nAChRs (Demmerly & Edmonds, 2015).
Whole-cell data is commonly analyzed by measuring the peak currents generated at 
multiple agonist concentrations and plotted as a dose-response relation to determine the efficacy 
(maximum response relative to other agonists) and potency (concentration that yields a half- 
maximal response) of an agonist. Modifying experimental procedures, such as the addition of an 
allosteric modulator, provides insight on changes in efficacy and potency under experimental 
conditions. The steady-state current, which indicates the effect of prolonged exposure to a 
compound, as is likely to happen in vivo (Brody et al., 2006), can be measured with the use of 
data analysis software such as Igor Pro. In addition, changes in the rate of decay of the peak 
current provide insight on the effect of a compound on the time course of development of 
desensitization.
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Chapter 2: Hypothesis
2.1 Nicotinic Receptors Have a High Probability of Opening
dFBr has been shown to cause a three-fold potentiation of the peak current in Xenopus 
laevis oocytes heterologously expressing a4p2 nAChRs (Weltzin & Schulte, 2010). The use of 
oocytes is associated with slow solution exchange times; therefore, potentiation observed in 
oocytes may not reflect potentiation in vivo, where agonist concentration rises rapidly. My 
experiments were designed to test whether or not this data is reproducible using smaller, 
mammalian cells, in which faster solution exchange times are possible.
LS receptors have a high probability of opening (Popen > 0.8) when agonist concentration 
is rapidly stepped, or jumped, to a saturating level of ACh or nicotine (Li & Steinbach, 2010; 
Demmerly & Edmonds, 2015). Based on this finding, one would not expect the potentiation of 
the peak current by dFBr to be greater than 25% of the control response. I, therefore, 
hypothesized that previous reports on the potentiating effects of dFBr were overestimated 
(Weltzin & Schulte, 2010).
2.2 Small Cell Size and Fast Solution Exchange Promotes Synchronous Activation of nAChRs
Cell size may significantly influence the rate at which one can change experimental 
solutions while voltage clamping. Oocytes have been used in electrophysiology experiments for 
decades, because of their relatively large size and ease of use in two-electrode voltage-clamping 
experiments, as well as their ease in maintenance. Smaller cell lines such as HEK-293 cells and 
SH-EP1 cells have also been used with increased frequency over the last few decades. In whole­
cell experiments, simultaneous exposure of the drug solution to the entire population of receptors
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on the cell is important due to the fact that nAChRs are known to be extremely fast activating, 
and can rapidly enter long-lived desensitized states, depending on the pharmacodynamics of the 
drug of interest (Paradiso & Steinbach, 2003). To observe a true peak response while voltage 
clamping, receptors must be activated synchronously. The relatively large surface area of oocytes 
presents a problem for simultaneous exposure of the drug to the entire population of expressed 
receptors (Baburin, Beyl, & Hering, 2006).
A phenomenon called the “unstirred layer effect” describes how ion transport is affected 
by surface area (Wilson & Dietschy, 1974). Essentially, the more surface area that a solution 
must cover, the more resistance the solution encounters, and the longer it takes to exchange 
solutes at the surface. Receptors that are closer to the (solution) application pipette are activated 
and desensitized before receptors that are further away, resulting in asynchronous activation of 
receptors.
Increasing the speed of solution exchange, in addition to choosing a cell with a smaller 
surface area, will further promote synchronous activation of all surface receptors. The solution 
exchange times done by Weltzin & Schulte (2010) were measured on the order of seconds, 
which is far too slow to capture the true peak current in a cell expressing a4p2 nAChRs.
To this point, Baburin et al. (2006) said, “Fast perfusion of oocytes [and other cell types] 
is [essential] for studies of ligand-gated ion channels. Large bath volumes and slow perfusion 
rates prevent fast and timed applications of neurotransmitters resulting in apparently slow 
applications of the channels and substantial receptor desensitization during the chamber 
perfusion leading to underestimation of the peak current values.”
Therefore, it is not unreasonable to hypothesize that there may actually be a large 
proportion of desensitized a4p2 nAChRs at the time that the “peak” current is measured in the
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oocyte preparation. If an allosteric modulator were to disrupt or destabilize desensitized states, 
potentiation in oocytes, where the fraction of desensitized receptors at the time of peak current is 
significant, would be expected to be large relative to potentiation of currents when receptors are 
activated rapidly (little or no desensitization). The advantage to testing my hypothesis in SH-EP1 
cells, as opposed to oocytes, is that SH-EP1 cells have a relatively small surface area, 
minimizing the unstirred layer effect and facilitating rapid solution exchange.
2.3 Activation of Silent Receptors
An important finding by Li & Steinbach (2010) yields another potential explanation for a 
three-fold potentiation of the peak current (Weltzin & Schulte, 2010) that deserves consideration. 
They showed that HEK cells express ~1000 functional a4p2 nAChRs, however, this number is 
only ~ 7% of the total number of receptors in the membrane as assessed in radioligand binding 
experiments (Zhang & Steinbach, 2003; Li & Steinbach, 2010). This observation is consistent 
with the possibility that the majority of surface receptors (93%) are “silent,” or not available for 
activation, for unknown reasons (Li & Steinbach, 2010; Papke, 2010). This phenomenon has also 
been observed in oocytes (Fenster, Whitworth, Sheffield, Quick, & Lester, 1999). A large 
potentiation of the peak current in SH-EP1 cells is not inconsistent with the idea that a portion of 
the otherwise silent receptors become available for activation in the presence of dFBr.
2.4 Whole-Cell Simulation Models Can Be Compared with Experimental Results
In addition, we felt that a whole-cell approach, by itself, would not provide us with an 
adequate understanding of how dFBr modulates a4p2 nAChRs. Although the details of the 
acquisition of single-channel data and its analysis is outside of the scope of this thesis,
11
concurrent whole-cell and single-channel data analysis was also used to determine the gating 
properties of individual receptors and how they are modulated by dFBr. If, using these 
techniques, one can conclude that the entire effect of potentiation can be accounted for by the 
modulation of gating properties by dFBr, this would decrease the likelihood that the potentiating 
effects of dFBr could be attributed to the recruitment of silent receptors.
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Chapter 3: Materials and Methods
3.1 Cell Culture
Cell media for SH-EP1 cells stably transfected with a4p2 nAChRs consisted of 500 mL 
Dulbecco’s Modified Eagle’s Medium (DMEM) (Gibco®, cat# 11965-092) containing 25 mL 
Fetal Bovine Serum (Hyclone® cat# SH30071.03), 50 mL Heat Inactivated Horse Serum 
(Gibco®, cat# 26050-088), 5 mL Sodium Pyruvate (Sigma®, cat# P5280-25G), 10 mL L- 
Glutamine (Sigma®, cat# G8540-25G), 5 mL Penicillin-Streptomycin (Cellgro®, cat# 30-002- 
CI), and 100 |iL of Amphotericin B (Sigma®, cat# A9528, 10mg/mL). Cells were seeded at a 
density of approximately 1 x 106 cells/ T-75 cell culture flask and incubated at 37o C in the 
presence of 5% CO2, and passaged every 3 days or when cell culture growth reached 90% 
confluency. 24 hours prior to experiments, SH-EP1 cells were plated on 35 mm culture dishes at 
a density of 1 x 105 cells/ dish with 3 mL of fresh media.
Freestyle™ human embryonic cells (HEK F-293) were used in a few preliminary 
experiments. Cells were maintained in suspension with Gibco© Freestyle™ 293 Expression 
Medium (Invitrogen®) at 37o C in the presence of 8% CO2. HEK F-293 cells were seeded at a 
density of 2 x 105 cells/mL and passaged every three days or when cell density exceeded 1.5 x 
106 cells/mL.
3.2 Transfection
HEK F-293 Cells were plated on 35 mm dishes at a density of 2 x 105 cells/mL and 
allowed to adhere to the dish approximately 24 hours prior to transfection. HEK F-293 cells were 
transiently transfected with 12 |ig of both a4 and P2 nicotinic receptor subunit DNA plasmids,
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and allowed to incubate in transfection solution at 37o C and 8% CO2 for 2-2.5 hours. After 
transfection incubation period, the transfection solution was removed by aspiration and replaced 
with fresh media. HEK F-293 cells were allowed to incubate for 24 hours at 37o C and 8% CO2 
prior to any electrophysiology experiments.
3.3 Electrophysiology
The extracellular recording solution was composed of deionized water containing 
(in mM) 142 NaCl, 2.0 CaCl2, 1.7 MgCl2, 5.0 Hepes, 10 Glucose, and 5.4 KCl. pH was adjusted 
to 7.4 with KOH and sterilized via vacuum filtration through a 0.22 micron filter. The pipette 
solution contained (in mM) 5.4 NaCl, 0.5 CaCl2, 4.0 MgCl2, 5.0 Hepes, 142 KCl, and 5.0 EGTA. 
pH was adjusted to 7.4 with NaOH and sterilized via vacuum filtration through a 0.22 micron 
filter. Appropriate concentrations of drug and agonist solutions were prepared from 1 M stock 
solutions of ACh and 10 mM stock solutions of dFBr in deionized water, degassed, and filtered 
with a 0.22 micron filter prior to experiments.
Pipettes were pulled to a resistance of 4-8 MQ using a PMP102 micropipette puller 
(Microdata Instrument Inc.), coated with Sylgard®, and front- and back-filled with pipette 
solution. Once the pipette was lowered into the 35 mm dish containing external recording 
solution using a ROE-200 Micromanipulator (Sutter Instruments), the pipette offset was dialed 
down to zero using an Axopatch 200B patch-clamp amplifier (Molecular Devices). After 
touching onto a cell, suction was applied until a seal (minimum resistance: 1 GQ) was achieved. 
Strong bursts of suction were applied until large transient spikes appeared on the oscilloscope in 
the Digidata 1440 interface and pClamp 10 acquisition software (Molecular Devices). 
Adjustments were made to compensate for pipette capacitance (“fast mag” and “fast t”), whole­
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cell capacitance, and series resistance allowing us to correct for voltage drop occurring at the 
pipette tip (series resistance error). Membrane voltage was held at -80 mV for all experiments 
except in a control experiment in which we tested the possibility of voltage-dependent channel 
block contributed our experiments.
Once in a whole-cell configuration, solutions were applied using a fast-application 
perfusion system (Lee Mini Valves supplied by Automate Scientific with Automate 
ValveLink8.2 Controller) pressurized at 0.5 psi. A Perfusion Pencil® multi-barrel manifold with 
250 micron removable tip was placed adjacent to the target cell so that the cell was directly in the 
solution stream, and viewed under a 40x water immersion objective (Nikon® Eclipse).
3.4 Whole-Cell Analysis
Values for peak current, 10-90 rise time, steady-state current, decay time constants, and 
associated amplitudes of fitted exponentials were determined using the software program Igor 
Pro, Version 6.05A (©WaveMetrics, Inc.). The desensitization portion of the waveforms were 
best fit using a double exponential function.
Equation 1: y = y0 + A! exp ( ^  x° ^  + A2 exp
Where y is the slope of the curve, y0 is the starting y value of the curve, A is the fractional 
amplitude of the component, t  is the time constant for the component, and x-x0 is the change in 
time. Changes in the average fractional contribution of Ai and A2, and changes in the mean 
values of t 1 and t2 in 100 ^M ACh and 100 ^M ACh + 1 ^M dFBr were then calculated.
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Chapter 4: Results
4.1 Controls
4.1.1 Speed of Perfusion System
Exchange rates between solutions were performed on HEK F-293 cells. Solution 
chambers were filled with external (High Na+) and internal (High K+) solutions. Solution 
exchanges resulted in changes in membrane current with a 10-90 rise time of approximately 50 
ms (Figure 1). The 10-90 rise time is one method used to measure the speed of the response by 
determining the time it takes to progress from 10% to 90% of the peak current.
Figure 1: Perfusion Speed. To determine the speed o f the perfusion system, external solutions were jumped from high [Na+] to
high [K+], and achieved 10-90 rise times o f —50 ms.
4.1.2 Contamination
To test that our recordings were not contaminated by accumulation of drugs in the bath 
(i.e., drugs outside of the direct solution stream), we performed the following sequence of
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solution exchanges: 500 ms control solution, 20 s of 100 (Weltzin & Schulte, 2015) ACh, 2 s 
control, 2 s 1 ^M dFBr. The experiment showed no response when the solution switched to 1 ^M 
dFBr. A positive control was performed using the same outline of solution exchanges replacing 1 
^M dFBr with 100 ^M ACh + 1 ^M dFBr, and a response was observed (data not shown).
4.1.3 Voltage Dependent Channel Block
To explore the possibility of voltage- dependent channel block interfering with 
experimental results, peak currents were measured using 100 ^M ACh and 100 ^M ACh + 1 ^M 
dFBr held at a membrane potential of -80 mV and repeated at -30 mV. The difference in fold 
potentiation between the two sample groups was negligible (1.56-fold and 1.48-fold increase, 
respectively).
4.2 Whole-Cell Data Analysis
Twenty-one whole-cell recordings (twelve with 100 ^M ACh and nine with 100 ^M ACh 
+ 1 ^M dFBr) performed on SH-EPi cells were analyzed to examine changes in peak current, 
10-90 rise time, steady-state current, and the fraction of the peak current in the steady-state. In 
addition, similar analyses were performed on whole-cell simulations of HS, LS, and 50% HS + 
50% LS receptors using gating models (provided by Demmerly and Edmonds, unpublished) 
generated from single channel data and were compared alongside the experimental data. Changes 
in the time constants (refer Equation 1), t 1 and t2, give insight as to changes in the rate of 
desensitization. Inconsistent results made it impossible to use this data in a meaningful way.
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The time to peak current differed widely depending on the cell, but I found, in general, 
that dFBr caused the current to peak more rapidly (Table 1). For example, the 10-90 rise time of 
Experiment 1 in 100 ^M ACh was 238 ms. That same cell in 100 ^M ACh + 1 ^M dFBr had a 
10-90 rise time of 66.5 ms. On average, dFBr yielded a ~38% reduction in the 10-90 rise time, 
but in two of the four cells, I did not observe a significant change in the 10-90 rise time.
4.2.1 Effects of dFBr on the Time to Peak Current
Table 1: Percent Change of 10-90 Rise Times in dFBr
ACh (ms) ACh + dFBr (ms) Percent Change in Rise Time
Experiment 1 238 66.5 -72.0%
Experiment 2 152 41.6 -72.8%
Experiment 3 106 97.9 -7.25%
Experiment 4 65.4 65.8 +0.65%
Average -37.9%
HS Simulation 25.5 11.1 -56%
LS Simulation 54.0 50.3 -6.85%
HS + LS Simulation 40.5 25.3 -37.5%
In the simulation models, the magnitude of the effect of dFBr on the 10-90 rise time was 
dependent on the distribution of HS and LS receptors (Table 1). dFBr had the greatest effect on 
the HS simulation, reducing the 10-90 rise time from ~25 ms to ~11 ms. The LS simulation 
yielded a slight reduction in the 10-90 rise time from ~54 ms to ~50 ms. The HS + LS simulation 
yielded a reduction in the 10-90 rise time from ~41 ms to ~25 ms, a ~38% reduction. Also, it is 
interesting to note the HS simulation reached its peak twice as fast as the LS simulation without 
dFBr, and about five times as fast with dFBr.
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100 [xM ACh produced inward currents in SH-EP1 cells expressing a4fi2 nAChRs. The 
currents peaked rapidly, followed by a decay of the inward current until it reached a steady-state. 
Co-application of 100 |iM ACh with 1 |iM dFBr produced inward currents that peaked, on 
average, with larger amplitudes than currents measured in 100 |iM ACh alone (Figure 2).
4.2.2 Effects of dFBr on the Peak Current
Figure 2: Potentiation o f the Peak Current by dFBr. Experimental data (Experiment 2) demonstrating the whole-cell response to 
100 |xM ACh (black) and 100 |xM ACh + dFBr (red). Common among these experiments was the observation that dFBr 
potentiates the peak current, decreases the time to peak, and changes the steady-state current at which the receptors are in 
equilibrium. This particular example demonstrated the largest (2-fold) potentiation o f all o f the recordings.
Consistent with my hypothesis, I observed a 1.57-fold mean increase in the peak current 
in dFBr (Table 2), which is much lower than what has been previously reported (Weltzin & 
Schulte, 2010). Potentiation of the peak current ranged from 1.23-fold potentiation to 2-fold 
potentiation of the peak current.
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When a similar analysis was performed on the HS, LS, and HS + LS simulations, the 
potentiating effects of dFBr on the peak currents increased 1.73-fold, 1.33-fold, and 1.26-fold, 
respectively (Figures 3, 4, and 5) (Table 2).
Figure 3: LS Simulation Model. A simulation model demonstrating the theoretical whole-cell response to 100 |xM ACh (black) 
and 100 |xM ACh + 1 |xM dFBr (red) on a cell expressing only LS receptors.
21
Figure 4: FIS Simulation Model. A simulation model demonstrating the theoretical whole-cell response to 100 |xM ACh (black) 
and 100 |xM ACh + 1 |xM dFBr (red) on a cell expressing only FIS receptors.
Figure 5: LS + FIS Simulation Model. A simulation model demonstrating the theoretical whole-cell response to 100 |xM ACh 
(black) and 100 |xM ACh + 1 |xM dFBr (red) on a cell expressing an equal ratio o f FIS and LS receptors.
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Table 2: Fold Change o f the Peak Current in
ACh (pA) ACh + dFBr (pA) Fold Change in dFBr
Experiment 1 -1740 -2430 +1.40
Experiment 2 -1110 -2230 +2.01
Experiment 3 -3461 -4263 +1.23
Experiment 4 -774 -1278 +1.65
Average + 1.57
HS Simulation -1534 -2651 +1.73
LS Simulation -2551 -3391 +1.33
HS + LS Simulation -3859 -4861 +1.26
HS Simulation * -1440 -1760 + 1.22
LS Simulation * -2252 -3182 + 1.41
HS + LS Simulation* -3678 -4833 + 1.31
* These values were taken at a common time point
One might expect to observe that the potentiation of the peak current of the HS + LS 
simulation would fall somewhere between the individual HS and LS simulations, however, I 
found that the potentiation of the peak current in the HS + LS simulation was smaller (+1.26- 
fold) than both the HS (+1.73-fold) and the LS (+1.33-fold) simulations. In measuring the 10-90 
rise times (above), the simulation models indicate that HS and LS receptors activate at different 
rates. In other words, the peak currents of the three models were occurring at different times. 
When I measured the current values at the 278 ms time point (the time half-way between the HS 
dFBr peak and the LS dFBr peak), the potentiation of the current (shown in bold in Table 2) 
measured in the LS + HS simulation was, in fact, half-way between the values measured for the 
HS and LS simulations individually. Thus, the peak currents measured in the simulation models 
were correct.
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When the current decays (desensitization) were fit with a double exponential function, 
the value for y0 was given and interpreted as the steady-state current value. The experimental 
data revealed a 1.5-fold increase in the steady-state current with dFBr (Figure 6), similar in 
magnitude to the HS simulation (1.55-fold increase). The LS simulation, however, showed an 
even larger (4.20-fold) increase in the steady-state current in dFBr (Table 3). It appears that there 
was little destabilization of desensitized states at equilibrium in the experimental results in 
comparison to the LS simulation model. Perhaps the HS:LS expression ratio in SH-EP1 cells is 
high. This finding was not anticipated in the experimental design, otherwise efforts could have 
been made to isolate HS and LS nAChRs.
4.2.3 Effects of dFBr on the Steady-State Current
Figure 6: Effect o f dFBr on the Steady-State Current. Representative whole-cell recording (Experiment 3) that highlights the 
effect o f dFBr on the steady-state current. The trace on the left was recorded with 100 |xM ACh alone. The trace on the right was 
recorded with 100 |xM ACh + 1 |xM dFBr. The steady-state currents were estimated with the dashed lines (100 |xM ACh in black 
and 100 |xM ACh + 1 |xM dFBr in red). Note that the steady-state values in this recording were larger than in other recordings, 
but the fold-increase in the steady-state current with dFBr was relatively consistent throughout my experiments.
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Table 3: Fold Change of the Steady-State Current in dFBr
ACh (pA) ACh + dFBr (pA) Fold Change in dFBr
Experiment 1 * N/A N/A N/A
Experiment 2 -428 -645 +1.51 fold
Experiment 3 -1402 -1966 +1.40 fold
Experiment 4 -86.6 -132 +1.53 fold
Average + 1.48 fold
HS Simulation -33.561 -51.99 +1.55 fold
LS Simulation -289 -1216 +4.20 fold
HS + LS Simulation -218 -1288 +5.90 fold
* The appearance o f the whole-cell recording made it difficult to confidently determine the steady-state current in 
this recording.
To compare waveforms directly, the experimental recordings in 100 ^M ACh alone were 
scaled up so that the peak currents were approximately the same size as the peak currents in 100 
^M ACh + 1 ^M dFBr (Figure 7). Similar scaling with the simulations were performed and 
shown in Figures 8, 9 and 10. On gross examination, the desensitizing sag of the experimental 
data had a similar shape, but with different times to peak (Figure 7). The LS simulation showed a 
similar time to peak, but the desensitization in dFBr developed more slowly (Figure 8). The HS 
simulation also showed a similar time to peak, but desensitized more quickly in dFBr (Figure 9). 
The HS + LS simulation also showed a similar time to peak. Like the LS simulation model, the 
HS + LS simulation desensitized more slowly in dFBr, but not as slow as the LS simulation 
(Figure 10).
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Figure 7: Normalization o f the Peak Current. The two traces from Figure 2 were normalized to the peak current to visualize how
dFBr affected the general shape o f the curve.
Figure 8: Normalization o f the Peak Current (LS Simulation). The two traces from Figure 3 were normalized to the peak current
to visualize how dFBr affected the general shape of the curve.
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Figure 9: Normalization o f the Peak Current (FIS Simulation). The two traces from Figure 4 were normalized to the peak current
to visualize how dFBr affected the general shape of the curve.
Figure 10: Normalization o f the Peak Current (LS + FIS Simulation). The two traces from Figure 5 were normalized to the peak 
current to visualize how dFBr affected the general shape o f the curve.
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Chapter 5: Discussion 
The significance of these findings relate, not only to dFBr and those who study how it 
modulates a4p2 nAChRs, but to all who utilize patch-clamping methods to study ligand-gating 
ion channels and other fast-activating ion channels. The importance of synchronous activation of 
all receptors is emphasized by this study. This principle is fundamental for accuracy and 
reproducibility, yet it is, unfortunately, commonly overlooked.
Significant findings include a ~1.5-fold potentiation of the peak current, ~1.5-fold 
potentiation of the steady-state current, and a 38% decrease in the 10-90 rise time when cells 
expressing a4p2 nAChRs were exposed to dFBr. This study also highlights a new perspective on 
how we might classify whether or not a drug is an allosteric modulator.
5.1 The Importance of Fast Application
I found that rapid solution exchange is crucial for capturing accurate peak currents in 
whole-cell experiments with fast-activating a4p2 nAChRs. We were able to achieve exchange 
rates with 10-90 rise times of approximately 50 ms in control experiments. Faster solution 
exchange rates were possible, however, our system was somewhat limited by the strength of the 
adherence of the cells to the petri dishes and to the pipette. Increased pressure in the perfusion 
system would have allowed for faster exchange rates, however, the cells had a tendency to blow 
away in the solution stream if the pressure was too great. We found that approximately 0.5-0.75 
psi to be the optimal pressure in the perfusion system, using a perfusion pencil with a diameter of 
250 microns.
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5.2 The Importance of Cell Selection
Cell culture and the selection of a cell line was an ongoing issue throughout my 
experiments. Several attempts were made at using different cell lines. Initially, experiments were 
performed using HEK-293 transiently transfected with a4 and P2 subunit DNA at equal ratios. 
An abundance of extracellular material and overcrowding of cells made it difficult to obtain 
quality seals on our whole-cell patches. The next endeavor was with HEK-F293 cells, which 
grew in a continuously-agitated solution. HEK-F293 cells had considerably less extracellular 
debris when plated, but lacked adequate adherence to the plates to allow for fast solution 
exchange. Finally, stably transfected SH-EP1 cells were used to acquire all of my experimental 
data, but it also was not without challenges. At times, extracellular debris also made it extremely 
difficult to obtain quality seals. Time and resources prevented the use of stably-transfected HEK- 
293 cells, which would have likely been more ideal for my experiments, considering that the 
ratio of LS to HS nAChRs has been previously determined in this cell type.
5.3 Potentiation of the Peak Current
On average, I observed a 1.57-fold increase in the peak current with dFBr, consistent 
with my hypothesis that previous reports (Weltzin & Schulte, 2010) were too high. Whole-cell 
simulation models for LS and HS receptors were similar to my experimental results, +1.33-fold 
and +1.73-fold, respectively, further supporting my hypothesis. The consistency of my 
experimental data with the simulation models also argues against the possibility that a 3-fold 
potentiation could be attributed to the recruitment of silent receptors by dFBr. More likely, these 
data suggest that the unstirred-layer effect has a greater impact on whole-cell experiments 
involving a4p2 nAChRs (and likely other types of fast-activating receptors) than has been
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realized in the past. Neglecting to minimize the unstirred layer effect by selecting small cell lines 
and optimizing perfusion speed can result in inaccuracies in the literature.
5.4 Effects of dFBr on Nicotinic Receptor Activation
dFBr decreased the 10-90 rise times in half of my experiments and in the HS simulation, 
while the 10-90 rise times in the other half of my experiments and the LS simulations were 
largely unaffected by dFBr. There are many variables that could have lead to this discrepancy. 
One may speculate that the ratio of LS to HS receptors expressed in individual SH-EP1 cells is 
not constant. Minute variations in temperature, cell culture, the integrity of the cell membrane, 
and/or allosteric interactions with other media reagents such as HEPES (Weltzin, Huang, & 
Schulte, 2014) could have significant impacts on gene expression, post-translational 
modifications, and dynamics of receptors. Also, variations in cell size and perfusion speed of the 
experimental solutions could cause mixed-results.
5.5 Effects of dFBr on Desensitization
On average, dFBr caused a ~1.5-fold increase in the steady-state current in my 
experimental results. In other words, there was more current passing through the membrane at 
equilibrium in the presence of dFBr. I think this finding is even more significant than the effect 
of dFBr on the peak current, because the steady-state current represents the (relatively) long­
term, rather than transient effects of dFBr on a4p2 nAChRs. This result further reinforces the 
argument that dFBr and other PAMs of a4p2 nAChRs could be more effective at treating 
cognitive disorders that result from decreased neuronal cholinergic activity, or augment current 
treatments. Interestingly, the effect of dFBr on the steady current in the simulation models was
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far more pronounced in the LS simulation than in the HS simulation. This may also be a very 
significant finding, considering that LS receptors make up approximately 80% of neuronal a4p2 
nAChRs (Nelson et al., 2003).
5.6 dFBr Modulates a4p2 nAChRs in a Stoichiometric-Dependent Manner
In the simulation models, the effect of dFBr was strikingly dependent on stoichiometry. 
There was a much larger (4.20-fold) increase in the steady-state current in the LS simulation, and 
there was barely any steady-state current observed in the HS simulation with or without dFBr. 
Although dFBr had a greater effect on the peak current in the HS simulation as compared to the 
LS simulation, the models showed that the current in the HS simulation reached the steady-state 
more rapidly in dFBr, inferring that dFBr increases the rate at which HS receptors enter one or 
more desensitized states, or decreases the rate at which they leave those states. The opposite 
effect was seen in the LS simulation. It took longer for the whole-cell response in the LS 
simulation to reach the steady-state in the presence of dFBr, and the current was significantly 
larger.
When the simulations were compared to the experimental data, it appeared as if there was 
a mixture of HS and LS nAChRs expressed in SH-EP1 cells. The average potentiation of the 
peak current by dFBr in the experimental results was approximately half-way between the 
potentiation seen in the HS and LS models.
I observed a significant steady-state current in all of my experimental results that was 
even more pronounced in dFBr, much like the LS simulation. However, the peak currents in my 
experimental results desensitized more quickly in the presence of dFBr, much like the HS 
simulation. Because of these mixed-results, I can only assume that there was a mixture of HS and
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LS receptors expressed in the experimental cells, but I am unable to quantify their relative 
distribution based on these observations alone. In order to make any definitive claims, one would 
need to isolate the receptor subtypes by using stoichiometry-specific agonists, concatenated 
receptors, or by adjusting the ratio of subunit DNA during transfection. It is also possible that the 
gating properties of a4p2 nAChRs are effected by the type of plasma membrane in which these 
receptors are expressed (HEK cells vs. SH-EP1 cells vs. oocytes, etc.).
5.7 Defining Modulation
Plotting a dose-response curve based on the peak currents measured under different 
concentration profiles is the standard for determining the modulating-effect of a drug. When a 
positive change in the peak current is measured, that drug is labeled as a PAM. Although 
important, my research has taught me that this is a somewhat narrow approach to defining 
modulation, because it only takes the peak current into account and neglects everything that 
follows the peak current, namely desensitization and the steady-state current. Because the peak 
current can be extremely transient and rapidly desensitized, I would encourage future research 
involving dFBr and other PAMs of a4p2 nAChRs to not neglect its effects on the steady-state 
current. Its effect on the steady-state in my experimental results and the simulation models is 
why I believe that dFBr has great potential as a therapeutic agent for the treatment of the 
cognitive disease mentioned previously. This information would be especially useful if dFBr or 
other PAMs of a4p2 nAChRs were studied in connection with AChEIs, where the effects of 
desensitization may be greatest due to prolonged exposure to ACh.
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Chapter 6: Conclusion
From these experiments, I am able to conclude that my hypothesis was correct; that 
optimizing fast solution exchange times made a difference in the observed modulating effects of 
dFBr, and that slow solution exchange yields an inappropriately high fraction of desensitized 
nAChRs at the peak. Therefore, when the requirement (for a useful drug) is to alter peak 
currents, the potential utility of compounds that act by modulating desensitized receptors will be 
overestimated. To reduce such errors, future in vitro research involving fast-activating receptors, 
such as a4p2 nAChRs, should be performed in smaller cell lines such as HEK-293 cells or SH- 
EP1 cells, and optimization of solution exchange times should be a critical part of the 
experimental design.
I can conclude that dFBr, in fact, potentiates the peak current measured in cells 
expressing a4p2 nAChRs. The results on the effect of dFBr on the rate of desensitization, 
however, were mixed. This could be due to variability in the expression ratio of HS and LS 
nAChRs in SH-EP1 cells. The simulation models indicate that dFBr modulates HS and LS 
nAChRs differently, which was not known to me prior to performing my experiments otherwise 
more efforts would have been made to isolate the whole-cell responses for HS and LS receptors 
to more accurately compare experimental results with the simulations.
Furthermore, I believe that the effects of dFBr on the steady-state current are significant; 
perhaps even more significant than its effect on the peak current. The increase in the steady-state 
current points to the fact that dFBr does, in fact, shift the ratio of nondesensitized to desensitized 
receptors at equilibrium. At the very least, the effect of dFBr on the steady-state current should 
be included in the discussion and an integral part of the assessment of an allosteric modulator.
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